Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata

J Am Acad Dermatol. 2017 Jul;77(1):167-170. doi: 10.1016/j.jaad.2017.03.024.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Adolescent
  • Alopecia Areata / drug therapy*
  • Child, Preschool
  • Female
  • Humans
  • Janus Kinases / antagonists & inhibitors*
  • Male
  • Nitriles
  • Piperidines / administration & dosage
  • Piperidines / therapeutic use*
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / administration & dosage
  • Pyrazoles / therapeutic use*
  • Pyrimidines / administration & dosage
  • Pyrimidines / therapeutic use*
  • Pyrroles / administration & dosage
  • Pyrroles / therapeutic use*
  • Skin Cream / therapeutic use

Substances

  • Nitriles
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • Pyrroles
  • ruxolitinib
  • tofacitinib
  • Janus Kinases

Associated data

  • ClinicalTrials.gov/NCT02812342
  • ClinicalTrials.gov/NCT02553330